Abstract | BACKGROUND AND OBJECTIVES: METHODS: Participated in this study 69 healthy term pregnant patients in active labor. Patients were randomly allocated in three groups receiving spinal combination of 2.5 mg hyperbaric bupivacaine and 1 mL saline solution (Control Group); 2.5 mg hyperbaric bupivacaine and 2.5 microg sufentanil (S2.5 Group) or 2.5 mg hyperbaric bupivacaine and 5 microg sufentanil (S5 Group). Pain, using a visual analogue scale (VAS), and side effects were evaluated at 5-minute intervals for the first 15 minutes and then at 15-minute interval until delivery. Study would end with delivery or when patient requested rescue analgesia (VAS > 3 cm). RESULTS: Groups S2.5 and S5 presented longer analgesia duration (67.2 +/- 38.6 and 78.9 +/- 38.7 minutes, respectively) and a larger number of patients with effective analgesia (100% and 95.6%, respectively) as compared to Control group where mean analgesia duration was 35.9 +/- 21.6 minutes (p < 0.05) with 69.6% of patients with effective analgesia (p < 0.05). CONCLUSIONS:
|
Authors | Eduardo Tsuyoshi Yamaguchi, José Carlos Almeida Carvalho, Ubirajara Sabbag Fonseca, Jacqueline Toshiko Hirahara, Mônica Maria Siaulys Capel Cardoso |
Journal | Revista brasileira de anestesiologia
(Rev Bras Anestesiol)
Vol. 54
Issue 2
Pg. 145-52
(Apr 2004)
ISSN: 1806-907X [Electronic] Brazil |
Vernacular Title | Sufentanil subaracnóideo associado à bupivacaína hiperbárica para analgesia de parto: E possível reduzir a dose do opióide? |
PMID | 19471722
(Publication Type: English Abstract, Journal Article)
|